MTOR and non-small cell lung carcinoma: Similar to the results with mTOR inhibition, Wnt inhibition using XAV939 resulted in a significant reduction in viability of H2170 resistant cells, suggesting that targeting the Wnt pathway may be a viable option for treating EGFR/c-Met TKI resistance in NSCLC.